Bioavailability and Pharmacokinetics
7
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions
Chrysin Bioavailability and Safety
Glucosamine Sulfate Bioavailability
Safety and Bioavailability of Micellar Green Tea Extract
Silymarin Bioavailability Study
Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules
Safety and Bioavailability of IV and SC LBR-101